Clinical Trial Update: Dexmedetomidine as an Adjuvant to Bupivacaine in Bilateral PECs for Pain Control After Cardiac Surgeries [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating dexmedetomidine as an adjuvant to bupivacaine in bilateral PEC nerve blocks for postoperative pain control after cardiac surge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Bupivacaine (Bupivacaine)
• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Kasr El Aini Hospital | Conditions: Post Operative Pain | Phase 4 | Status: COMPLETED